Using prescription patterns in primary care to derive new quality indicators for childhood community antibiotic prescribing

Pediatric Infectious Disease Journal

Volumn 35, Issue 12, 2016, Pages 1317-1323

  De Bie, Sandra ^a   Kaguelidou, Florentia ^a,b   Verhamme, Katia M C ^a   De Ridder, Maria ^a   Picelli, Gino ^c   Straus, Sabine M J M ^a,d   Giaquinto, Carlo ^e   Stricker, Bruno H ^a   Bielicki, Julia ^f   Sharland, Mike ^f   Sturkenboom, Miriam C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HÔPITAL ROBERT DEBRÉ   (France)

^c International Pharmacoepidemiology and Pharmacoeconomics Research Center   (Italy)

^d MEDICINES EVALUATION BOARD   (Netherlands)

^e Societa Italiana di Medicina Generale   (Italy)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antibiotic; Outpatient; Pediatrics; Pharmacoepidemiology; Quality

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BETA LACTAMASE INHIBITOR; CEFIXIME; CEFPODOXIME; CEFTIBUTEN; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CHILDHOOD; COHORT ANALYSIS; COMMUNITY; DRUG UTILIZATION; HUMAN; INFANT; ITALY; MAJOR CLINICAL STUDY; NETHERLANDS; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY CONTROL; RETROSPECTIVE STUDY; UNITED KINGDOM; CLINICAL PRACTICE; EPIDEMIOLOGY; EUROPE; HEALTH CARE QUALITY; NEWBORN; OUTPATIENT; PHARMACOEPIDEMIOLOGY; PRESCHOOL CHILD; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DRUG PRESCRIPTIONS; EUROPE; HUMANS; INFANT; INFANT, NEWBORN; OUTPATIENTS; PHARMACOEPIDEMIOLOGY; PRACTICE PATTERNS, PHYSICIANS'; PRIMARY HEALTH CARE; QUALITY INDICATORS, HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 84987597535     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000001324     Document Type: Article

References (41)

1. Tacconelli E. Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings. Curr Opin Infect Dis. 2009;22:352-358.
2. Adriaenssens N, Coenen S, Versporten A, et al; ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe. J Antimicrob Chemother. 2011;66 Suppl 6:vi71-vi77.
3. Ferech M, Coenen S, Malhotra-Kumar S, et al; ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother. 2006;58:401-407.
4. Sturkenboom MC, Verhamme KM, Nicolosi A, et al; TEDDY European Network of Excellence. Drug use in children: cohort study in three European countries. BMJ. 2008;337:a2245.
5. Sharland M; SACAR Paediatric Subgroup. The use of antibacterials in children: a report of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR) Paediatric Subgroup. J Antimicrob Chemother. 2007;60(suppl 1):i15-i26.
6. Sharland M, Kendall H, Yeates D, et al. Antibiotic prescribing in general practice and hospital admissions for peritonsillar abscess, mastoiditis, and rheumatic fever in children: time trend analysis. BMJ. 2005;331:328-329.
7. Spyridis N, Sharland M. The European Union Antibiotic Awareness Day: the paediatric perspective. Arch Dis Child. 2008;93:909-910.
8. Coenen S, Ferech M, Haaijer-Ruskamp FM, et al; ESAC Project Group. European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care. 2007;16:440-445.
9. van der Lei J, Duisterhout JS, Westerhof HP, et al. The introduction of computer-based patient records in The Netherlands. Ann Intern Med. 1993;119:1036-1041.
10. Vlug AE, van der Lei J, Mosseveld BM, et al. Postmarketing surveillance based on electronic patient records: the IPCI project. Methods Inf Med. 1999;38:339-344.
11. Lewis JD, Schinnar R, Bilker WB, et al. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf. 2007;16:393-401.
12. Sturkenboom M, Nicolosi A, Cantarutti L, et al; NSAIDs Paediatric Research Group. Incidence of mucocutaneous reactions in children treated with niflumic acid, other nonsteroidal antiinflammatory drugs, or nonopioid analgesics. Pediatrics. 2005;116:e26-e33.
13. Sturkenboom M. Other European databases for pharmacoepidemiology. In: Mann RD, Andrews EB, eds. Pharmacovigilance. Chichester: John Wiley, 2007.
14. Salvador Rosa A, Moreno Perez JC, Sonego D, et al. [The BIFAP project: database for pharmaco-epidemiological research in primary care]. Aten Primaria. 2002;30:655-661.
15. Coloma PM, Schuemie MJ, Trifire G, et al; EU-ADR Consortium. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf. 2011;20:1-11.
16. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment. Available from: http://www. whocc.no/. Accessed January 14, 2013.
17. Wettermark B, Pehrsson A, Jinnerot D, et al. Drug utilisation 90% profiles-A useful tool for quality assessment of prescribing in primary health care in Stockholm. Pharmacoepidemiol Drug Saf. 2003;12:499-510.
18. Bergman U, Popa C, Tomson Y, et al. Drug utilization 90%-A simple method for assessing the quality of drug prescribing. Eur J Clin Pharmacol. 1998;54:113-118.
19. Porta A, Hsia Y, Doerholt K, et al. Comparing neonatal and paediatric antibiotic prescribing between hospitals: a new algorithm to help international benchmarking. J Antimicrob Chemother. 2012;67:1278-1286.
20. Clavenna A, Bonati M. Differences in antibiotic prescribing in paediatric outpatients. Arch Dis Child. 2011;96:590-595.
21. Holstiege J, Enders D, Schink T, et al. Trends in paediatric macrolide use in five European countries-A population-based study. Eur J Clin Pharmacol. 2015;71:991-999.
22. Holstiege J, Schink T, Molokhia M, et al. Systemic antibiotic prescribing to paediatric outpatients in 5 European countries: a population-based cohort study. BMC Pediatr. 2014;14:174.
23. Holstiege J, Garbe E. Systemic antibiotic use among children and adolescents in Germany: a population-based study. Eur J Pediatr. 2013;172:787-795.
24. Recommendations for Management of Common Childhood Conditions: Evidence for Technical Update of Pocket Book Recommendations: Newborn Conditions, Dysentery, Pneumonia, Oxygen Use and Delivery, Common Causes of Fever, Severe Acute Malnutrition and Supportive Care. Geneva: World Health Organization; 2012. Available from: https://www. ncbi.nlm.nih.gov/books/NBK138333/.
25. Bradley JS, Byington CL, Shah SS, et al. The management of communityacquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. Clin Infect Dis. 2011;53:e25-e76.
26. Esposito S. Management of community-Acquired pneumonia in infants and children older than 3 months. Clin Infect Dis. 2012;54:884-5; author reply 885.
27. Harris M, Clark J, Coote N, et al; British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax. 2011;66(suppl 2):ii1-i23.
28. Elseviers MM, Ferech M, Vander Stichele RH, et al; ESAC project group. Antibiotic use in ambulatory care in Europe (ESAC data 1997-2002): trends, regional differences and seasonal fluctuations. Pharmacoepidemiol Drug Saf. 2007;16:115-123.
29. Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009;302:758-766.
30. Schneider-Lindner V, Quach C, Hanley JA, et al. Secular trends of antibacterial prescribing in UK paediatric primary care. J Antimicrob Chemother. 2011;66:424-433.
31. Esposito S, Cohen R, Domingo JD, et al. Antibiotic therapy for pediatric community-Acquired pneumonia: do we know when, what and for how long to treat? Pediatr Infect Dis J. 2012;31:e78-e85.
32. Xu KT, Roberts D, Sulapas I, et al. Over-prescribing of antibiotics and imaging in the management of uncomplicated URIs in emergency departments. BMC Emerg Med. 2013;13:7.
33. Dryden M, Johnson AP, Ashiru-Oredope D, et al. Using antibiotics responsibly: right drug, right time, right dose, right duration. J Antimicrob Chemother. 2011;66:2441-2443.
34. Finkelstein JA, Davis RL, Dowell SF, et al. Reducing antibiotic use in children: a randomized trial in 12 practices. Pediatrics. 2001;108:1-7.
35. Dommergues MA, Hentgen V. Decreased paediatric antibiotic consumption in France between 2000 and 2010. Scand J Infect Dis. 2012;44:495-501.
36. Sabuncu E, David J, Bernide-Bauduin C, et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med. 2009;6:e1000084.
37. Clavenna A, Sequi M, Bonati M. Differences in the drug prescriptions to children by Italian paediatricians and general practitioners. Eur J Clin Pharmacol. 2010;66:519-524.
38. Chiappini E, Regoli M, Bonsignori F, et al. Analysis of different recommendations from international guidelines for the management of acute pharyngitis in adults and children. Clin Ther. 2011;33:48-58.
39. Chiappini E, Principi N, Mansi N et al. Management of acute pharyngitis in children: summary of the Italian National Institute of Health guidelines. Clin Ther 2012;34:1442-1458e2.
40. Piovani D, Clavenna A, Cartabia M, et al; Antibiotic Collaborative Group. The regional profile of antibiotic prescriptions in Italian outpatient children. Eur J Clin Pharmacol. 2012;68:997-1005.
41. Gerber JS, Prasad PA, Fiks AG, et al. Durability of benefits of an outpatient antimicrobial stewardship intervention after discontinuation of audit and feedback. JAMA. 2014;312:2569-2570.